| Application no. and date | 20172615.5 (espacenet) (Federated) (European Patent Register), 20121226 | | Patent/reg. no. and date | DK/EP 3756650, 20250820 | | Publication date | 20201230 | | Priority no. and date | US 201161580626 P, 20111227 | | EP pub. no. and date |
EP 3756650 20201230 | | Effective date | | | Applicant/owner | Amgen (Europe) GmbH, Floor 6-8
Suurstoffi 22
Risch-Rotkreuz 6343, CH | | Applicant ref. no. | 2025895 | | Inventor | KELLY, Michael T., 43 Lorettacong Drive
Lake Hopatcong, NJ 07849, US,
BHAT, Sreenivas S., 12 Jared Boulevard
Kendall Park, NJ 08824, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61K 9/00 (2006.01) , A61K 9/28 (2006.01) , A61P 29/00 (2006.01) | | Title | FORMULERINGER AF (+)-2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHANSULFONYL-ETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
